Hosein Vakili1, Roxana Sadeghi2, Kobra Doustali1, Habibollah Saadat1, Mohammad Hasan Namazi1, Morteza Safi1. 1. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran. 2. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran ; Department of Cardiovascular , Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Abstract
BACKGROUND: Peripheral arterial disease is associated with adverse cardiovascular outcomes. As such, it is found that screening for peripheral arterial disease (PAD) improves risk assessment. Thus, intensive risk factor modification and medical treatment in these patients are necessary. OBJECTIVES: The purpose of this study was to determine the prevalence of asymptomatic peripheral arterial disease in patients with concomitant coronary arterial disease. METHODS: Asymptomatic peripheral arterial disease was investigated in 400 patients (60% males, 40% females, aged 59.7± 11.3) with a documented coronary arterial disease. RESULTS: Among patients with documented CAD, 12% had asymptomatic PAD with the ABI ratio of less than 0.9. CONCLUSIONS: It is advisable to screen for PAD not only as a disease but also as a risk assessment method for atherosclerosis.
BACKGROUND:Peripheral arterial disease is associated with adverse cardiovascular outcomes. As such, it is found that screening for peripheral arterial disease (PAD) improves risk assessment. Thus, intensive risk factor modification and medical treatment in these patients are necessary. OBJECTIVES: The purpose of this study was to determine the prevalence of asymptomatic peripheral arterial disease in patients with concomitant coronary arterial disease. METHODS: Asymptomatic peripheral arterial disease was investigated in 400 patients (60% males, 40% females, aged 59.7± 11.3) with a documented coronary arterial disease. RESULTS: Among patients with documented CAD, 12% had asymptomatic PAD with the ABI ratio of less than 0.9. CONCLUSIONS: It is advisable to screen for PAD not only as a disease but also as a risk assessment method for atherosclerosis.
Authors: P Greenland; J Abrams; G P Aurigemma; M G Bond; L T Clark; M H Criqui; J R Crouse; L Friedman; V Fuster; D M Herrington; L H Kuller; P M Ridker; W C Roberts; W Stanford; N Stone; H J Swan; K A Taubert; L Wexler Journal: Circulation Date: 2000-01-04 Impact factor: 29.690
Authors: Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson Journal: Am Heart J Date: 2002-06 Impact factor: 4.749
Authors: J D Hooi; A D M Kester; H E J H Stoffers; P E L M Rinkens; J A Knottnerus; J W van Ree Journal: J Clin Epidemiol Date: 2004-03 Impact factor: 6.437
Authors: Alan T Hirsch; Timothy P Murphy; Marge B Lovell; Gwen Twillman; Diane Treat-Jacobson; Eileen M Harwood; Emile R Mohler; Mark A Creager; Robert W Hobson; Rose Marie Robertson; W James Howard; Paul Schroeder; Michael H Criqui Journal: Circulation Date: 2007-09-17 Impact factor: 29.690
Authors: Ayman A Hussein; Kiyoko Uno; Kathy Wolski; Samir Kapadia; Paul Schoenhagen; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls Journal: J Am Coll Cardiol Date: 2011-03-08 Impact factor: 24.094
Authors: A T Hirsch; S L Halverson; D Treat-Jacobson; P S Hotvedt; M M Lunzer; S Krook; S Rajala; D B Hunninghake Journal: Vasc Med Date: 2001 Impact factor: 3.239
Authors: Edward W Gregg; Paul Sorlie; Ryne Paulose-Ram; Qiuping Gu; Mark S Eberhardt; Michael Wolz; Vicki Burt; Lester Curtin; Michael Engelgau; Linda Geiss Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112
Authors: Stefan F Lange; Hans-Joachim Trampisch; David Pittrow; Harald Darius; Matthias Mahn; Jens R Allenberg; Gerhart Tepohl; Roman L Haberl; Curt Diehm Journal: BMC Public Health Date: 2007 Impact factor: 3.295